Literature DB >> 30221544

Detection of m6A-associated SNPs as potential functional variants for coronary artery disease.

Xing-Bo Mo1,2,3, Shu-Feng Lei1,2,3, Yong-Hong Zhang1,3, Huan Zhang1,3.   

Abstract

AIM: To investigate the effects of m6A-single nucleotide polymorphisms (SNPs) on coronary artery disease (CAD).
METHODS: We examined the association of m6A-SNPs with CAD in about 185,000 cases and controls and further performed eQTL and differential expression analyses to support the identified m6A-SNPs.
RESULTS: Among the 4390 m6A-SNPs detected, 304 seemed to be associated with CAD (p < 0.05). SNP rs12286 was significantly associated with CAD at genome-wide level (p = 4.5 × 10-9). rs12286 was predicted to influence m6A methylation and have the potential to alter regulatory motifs binding, which may in turn regulate the expression of ADAMTS7 (p = 1.26 × 10-8).
CONCLUSION: The present study found plenty of CAD-associated m6A-SNPs and demonstrated the potential functionality of the identified SNPs.

Entities:  

Keywords:  ADAMTS7; FTO; coronary artery disease; eQTL; gene expression; genome-wide association study; m6A; multifunctional variants; single nucleotide polymorphism; transcription regulation

Mesh:

Substances:

Year:  2018        PMID: 30221544     DOI: 10.2217/epi-2018-0007

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  11 in total

1.  GAS5/METTL14/ESR1 genetic variants are related to the susceptibility of coronary heart disease.

Authors:  Yuxiao Sun; Zhaoyun Cheng; Mingxia Cui; Yan Chen; Ruigang Xie; Guoqing Lu; Chuanyu Gao
Journal:  Funct Integr Genomics       Date:  2022-03-02       Impact factor: 3.410

2.  ALKBH5 inhibits TNF-α-induced apoptosis of HUVECs through Bcl-2 pathway.

Authors:  Xiaoshan Zhang; ShiBing Deng; Yang Peng; Han Wei; Zhiming Tian
Journal:  Open Med (Wars)       Date:  2022-06-15

3.  Shared genetic etiology and causality between body fat percentage and cardiovascular diseases: a large-scale genome-wide cross-trait analysis.

Authors:  Zhenhuang Zhuang; Minhao Yao; Jason Y Y Wong; Zhonghua Liu; Tao Huang
Journal:  BMC Med       Date:  2021-04-29       Impact factor: 8.775

4.  Exploring the Epigenetic Regulatory Role of m6A-Associated SNPs in Type 2 Diabetes Pathogenesis.

Authors:  Miao Chen; Weimin Lin; Jianru Yi; Zhihe Zhao
Journal:  Pharmgenomics Pers Med       Date:  2021-10-27

Review 5.  Epitranscriptomics of cardiovascular diseases (Review).

Authors:  Stefanos Leptidis; Eleni Papakonstantinou; Kalliopi Io Diakou; Katerina Pierouli; Thanasis Mitsis; Konstantina Dragoumani; Flora Bacopoulou; Despina Sanoudou; George P Chrousos; Dimitrios Vlachakis
Journal:  Int J Mol Med       Date:  2021-11-18       Impact factor: 4.101

6.  Novel Associations Between METTL3 Gene Polymorphisms and Pediatric Acute Lymphoblastic Leukemia: A Five-Center Case-Control Study.

Authors:  Xiaoping Liu; Libin Huang; Ke Huang; Lihua Yang; Xu Yang; Ailing Luo; Mansi Cai; Xuedong Wu; Xiaodan Liu; Yaping Yan; Jianyun Wen; Yun Cai; Ling Xu; Hua Jiang
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

Review 7.  Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases.

Authors:  Vilbert Sikorski; Antti Vento; Esko Kankuri
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-20       Impact factor: 10.183

8.  m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease.

Authors:  Zhaoshui Li; Yanjie Song; Meng Wang; Ruxin Shen; Kun Qin; Yu Zhang; Ting Jiang; Yifan Chi
Journal:  Front Cardiovasc Med       Date:  2022-08-25

9.  Coronary artery disease risk factors affected by RNA modification-related genetic variants.

Authors:  Ru Li; Huan Zhang; Fan Tang; Chengcheng Duan; Dan Liu; Naqiong Wu; Yonghong Zhang; Laiyuan Wang; Xingbo Mo
Journal:  Front Cardiovasc Med       Date:  2022-09-20

Review 10.  Role of m6A RNA methylation in cardiovascular disease (Review).

Authors:  Yuhan Qin; Linqing Li; Erfei Luo; Jiantong Hou; Gaoliang Yan; Dong Wang; Yong Qiao; Chengchun Tang
Journal:  Int J Mol Med       Date:  2020-10-06       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.